DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $988,000 | -80.6% | 49,026 | -64.1% | 0.00% | -100.0% |
| Q2 2021 | $5,098,000 | +293.4% | 136,595 | +169.7% | 0.00% | +100.0% |
| Q1 2021 | $1,296,000 | +7.6% | 50,653 | -7.3% | 0.00% | 0.0% |
| Q4 2020 | $1,204,000 | +64.3% | 54,658 | +34.2% | 0.00% | 0.0% |
| Q3 2020 | $733,000 | -23.6% | 40,722 | +7.7% | 0.00% | 0.0% |
| Q2 2020 | $960,000 | +159.5% | 37,816 | +87.5% | 0.00% | – |
| Q1 2020 | $370,000 | -68.9% | 20,168 | -62.7% | 0.00% | -100.0% |
| Q4 2019 | $1,189,000 | -83.7% | 54,034 | -89.3% | 0.00% | -80.0% |
| Q3 2019 | $7,274,000 | -16.2% | 506,634 | -8.1% | 0.01% | 0.0% |
| Q2 2019 | $8,684,000 | +12.5% | 551,525 | +4.6% | 0.01% | 0.0% |
| Q1 2019 | $7,722,000 | +43.0% | 527,257 | +4.3% | 0.01% | +25.0% |
| Q4 2018 | $5,400,000 | -50.7% | 505,306 | -29.6% | 0.00% | +33.3% |
| Q3 2018 | $10,953,000 | +18.1% | 717,882 | -5.2% | 0.00% | 0.0% |
| Q2 2018 | $9,275,000 | +44066.7% | 757,243 | +34320.1% | 0.00% | – |
| Q1 2018 | $21,000 | -98.6% | 2,200 | -98.7% | 0.00% | -100.0% |
| Q4 2017 | $1,520,000 | +411.8% | 168,400 | +225.8% | 0.00% | – |
| Q3 2017 | $297,000 | +379.0% | 51,681 | +179.4% | 0.00% | – |
| Q1 2017 | $62,000 | -47.5% | 18,500 | -54.9% | 0.00% | – |
| Q4 2016 | $118,000 | -2.5% | 41,050 | +98.9% | 0.00% | – |
| Q3 2016 | $121,000 | -41.3% | 20,637 | -70.1% | 0.00% | – |
| Q2 2016 | $206,000 | -31.8% | 68,918 | +21.4% | 0.00% | – |
| Q1 2016 | $302,000 | -38.7% | 56,791 | +36.5% | 0.00% | – |
| Q4 2015 | $493,000 | +5.6% | 41,598 | -27.0% | 0.00% | – |
| Q3 2015 | $467,000 | -39.1% | 56,964 | +3.4% | 0.00% | – |
| Q2 2015 | $767,000 | – | 55,069 | +611777.8% | 0.00% | – |
| Q1 2015 | $0 | – | 9 | +350.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 2 | -100.0% | 0.00% | – |
| Q3 2014 | $155,000 | +604.5% | 12,247 | +1137.1% | 0.00% | – |
| Q2 2014 | $22,000 | -94.1% | 990 | -92.5% | 0.00% | – |
| Q1 2014 | $371,000 | – | 13,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |